Using Discrete Choice Experiments in Health Economics: Theoretical and Practical Issues 2019
 
Leaders and Presenters

Professor Mandy Ryan

Mandy is the Director of the Health Economics Research Unit. Her research has focused on developing methods of valuation in health economics, with a focus on discrete choice experiments and contingent valuation. Mandy has worked with academics, government and the pharmaceutical industry. Mandy has published widely in the field of health economics  generally, and monetary valuation more specifically. In 2012 Mandy was ranked amongst the top health economists in the world, placed 21st on the list of the top 100 health economists, based on a measure of health economics publications and the number of times they have been cited, making her the top-ranked health economist in the UK.
 
Dr Deborah Marshall

Deborah is a Professor at University of Calgary, who is actively engaged in advancing the methods and applying stated preferences research. She is a member of the Stated Preferences Methods Task Forces of the International Society for Pharmacoeconomics and Outcomes Research to develop good research practice methods for discrete choice experiments in health applications. She has worked in academia, government agencies, and industry in North America and Europe and has published widely in the field.

Dr Verity Watson
 
Verity is a senior research fellow at HERU and theme leader for the Methods of Benefit Valuation research theme. Dr Watson’s expertise is non-market valuation using contingent valuation and discrete choice experiments. Her research focusses on testing the validity of nonmarket valuation methods and how study context can influence responses. Dr Watson has applied these methods to inform a range of policy issues. In doing so she has worked with academics from a number of different fields, the government and the pharmaceutical industry.

Dr Gillian Currie
 
Gillian is a health economist and an Adjunct Associate Professor at the University of Calgary. She has research experience applying stated preference methods, including discrete choice experiments. A key focus of Gillian’s current research is measuring the preferences of physicians and families for biologic treatment initiation and tapering strategies among children with juvenile idiopathic arthritis (JIA).

Dr Luis Rebolledo Loria
 
Luis is a Research Fellow at HERU. Dr. Loria has a PhD in Economics with research focus in valuation of air quality, specifically for reductions in pollutants with adverse health outcomes, using stated and revealed preference methods. His research also includes the development of Decision Aid Tools using discrete choice experiments. He is currently part of a research team developing a decision aid tool for the management of persistent pain at the pharmacy level. Luis has an interest in the use of reference-dependent choice models and has taken part in the design of discrete choice experiments that apply these in the environmental economics field. His PhD thesis investigated preferences for emissions reduction in buses using the Aberdeen Hydrogen Bus Project as a case study.

Karen MacDonald
 
Karen MacDonald is a Research Manager at the University of Calgary in the field of health services and health economics research. Karen manages numerous large scale national and international grant funded research projects which use discrete choice experiment methods. She has experience developing, designing and using discrete choice experiments in diverse patient populations and a range of health care topics.